Sleeping pill reduces levels of Alzheimer’s proteins

Sleeping pill reduces levels of Alzheimer’s proteins

An FDA-approved sleeping pill reduced levels of Alzheimer’s proteins in a small study of healthy volunteers led by School of Medicine researchers. The study hints at the potential of sleep medications to slow or stop Alzheimer’s progression, although much more research is needed regarding such an approach.
Focused ultrasound technique leads to release of neurodegenerative disorders biomarkers

Focused ultrasound technique leads to release of neurodegenerative disorders biomarkers

Research from the lab of Hong Chen, at the McKelvey School of Engineering and the School of Medicine, and collaborators found that using focused-ultrasound-mediated liquid biopsy in a mouse model released more tau proteins and another biomarker into the blood than without the intervention. This noninvasive method could facilitate diagnosis of neurodegenerative disorders.

Cruchaga awarded Zenith Fellowship Award

Carlos Cruchaga, at the School of Medicine, has received a 2022 Zenith Fellow Award from the Alzheimer’s Association. The annual award is given to scientists who have made significant contributions to Alzheimer’s disease research and are likely to continue to do so.
Older Stories